Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H5F3N2OS |
Molecular Weight | 234.198 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC2=CC=C(OC(F)(F)F)C=C2S1
InChI
InChIKey=FTALBRSUTCGOEG-UHFFFAOYSA-N
InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)
Molecular Formula | C8H5F3N2OS |
Molecular Weight | 234.198 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:56:10 UTC 2023
by
admin
on
Fri Dec 15 15:56:10 UTC 2023
|
Record UNII |
7LJ087RS6F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N07XX02
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
FDA ORPHAN DRUG |
508715
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
LIVERTOX |
NBK548919
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
NDF-RT |
N0000167094
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
FDA ORPHAN DRUG |
509415
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
NDF-RT |
N0000167094
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
FDA ORPHAN DRUG |
510015
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
FDA ORPHAN DRUG |
563216
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
NDF-RT |
N0000167094
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RILUZOLE ZENTIVA (AUTHORIZED: AMYOTROPHIC LATERAL SCLEROSIS)
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
FDA ORPHAN DRUG |
72792
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
NDF-RT |
N0000167094
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
NDF-RT |
N0000175740
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
FDA ORPHAN DRUG |
100796
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
WHO-VATC |
QN07XX02
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
RILUTEK (AUTHORIZED: AMYOTROPHIC LATERAL SCLEROSIS)
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/14/1401
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
||
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2326
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
GG-81
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
D019782
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
7LJ087RS6F
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
1744-22-5
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
Riluzole
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
DB00740
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
7LJ087RS6F
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
5070
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
35623
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | RxNorm | ||
|
5912
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
SUB10319MIG
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
RILUZOLE
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
753433
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
1604337
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
2382
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
DTXSID3045192
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
759823
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
m9620
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL744
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
C47704
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY | |||
|
100000089184
Created by
admin on Fri Dec 15 15:56:10 UTC 2023 , Edited by admin on Fri Dec 15 15:56:10 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TARGET -> INHIBITOR |
Inhibits TDP-43 hyperphosphorylation
IC50
|
||
|
TARGET -> INHIBITOR |
INHIBITS GLUTAMATE RELEASE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
DOSE PHARMACOKINETIC PHARMACOKINETIC |
|
||
Cmax | PHARMACOKINETIC |
|
ROUTE OF ADMINISTRATION PHARMACOKINETIC |
|
||